Mr. Chris Wagner reports

EMERALD HEALTH THERAPEUTICS FULFILLING SUPPLY COMMITMENTS WITH PROVINCIAL ADULT-USE CANNABIS SHIPMENTS

Emerald Health Therapeutics Inc. has completed its first shipments of adult-use cannabis, fulfilling its initial supply scheduling, product and volume commitments in British Columbia as well as Newfoundland and Labrador -- an important milestone for the company as it significantly ramps up production and sourcing of cannabis and cannabinoid products. Emerald Health Therapeutics' products have been available in these provinces since Oct. 31, 2018.

"It has always been important to us to ensure we fulfill the supply commitments we made to our provincial cannabis distribution customers. We are pleased that our initial deliveries have met this obligation and that we have the ability to provide consistent and increasing contracted shipments of Emerald products," commented Paul Dillman, Emerald Health Therapeutics' executive vice-president of global sales and marketing. "With proprietary market research, differentiated products based on unique plant genetics, a recognizable, trusted brand, significant marketing expertise and bandwidth, and a growing sales team across Canada, we are aiming for a significant ramp-up in sales every quarter from these initial deliveries forward."

"Emerald aims to assure its customers a secure supply of an array of products by establishing significant, diverse sources of indoor-, greenhouse- and outdoor-grown cannabis and cannabinoid products. We have a strong and building foundation to achieve this goal," commented Chris Wagner, chief executive officer at Emerald Health Therapeutics. "Our products are now available in stores and on-line in B.C. as well as Newfoundland and Labrador. Emerald is in negotiations with cannabis distribution authorities in several provinces as we continue to scale our production and sourcing efforts."

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics is a licensed producer under Canada's Access to Cannabis for Medical Purposes Regulations. Emerald Health Therapeutics' 50-per-cent-owned Pure Sunfarms in British Columbia is completing a sophisticated 1.1-million-square-foot greenhouse; its Agro-Biotech operation in Quebec is completing a 75,000-square-foot indoor facility. Both facilities are in commercial production. Emerald Health Therapeutics has also contracted for approximately 500 acres of hemp harvest in 2018 and 1,000 acres in 2019 to 2022 with the goal of extracting low-cost cannabidiol.

We seek Safe Harbor.